Synapse - Naiyer Rizvi

Search Within

Naiyer A Rizvi

Results (166)

Preliminary clinical safety and activity of MK-3475 monotherapy for the treatment of previously treated patients with non-small cell lung cancer (NSCLC)

Meeting Abstract

Garon, E. B.; Balmanoukian, A.; Hamid, O.; Hui, R. N.; Gandhi, L.; Leighl, N.; Gubens, M. A.; Goldman, J.; Lubiniecki, G. M.; Lunceford, J.; more...
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

Ret fusion-positive advanced lung cancers: Response to first-line chemotherapy and survival in comparison to ROS1 and ALK fusion-positive and EGFR- and KRAS-mutant lung cancers

Meeting Abstract

Drilon, A.; Wang, L.; Joubert, P.; Snyder, A.; Cho, E. J.; Riely, G.; Kris, M.; Ladanyi, M.; Rizvi, N.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

Combination of the MEK inhibitor, pimasertib (MSC1936369B), and the PI3K/mTOR inhibitor, SAR245409, in patients with advanced solid tumors: Results of a phase Ib dose-escalation trial

Meeting Abstract

Infante, J. R.; Gandi, L.; Shapiro, G.; Rizvi, N.; Burris, H. A.; Bendell, J. C.; Baselga, J.; Hsu, K.; von Richter, O.; Locatelli, G.; more...
Cancer Research (2013)

Fulltext@MSK | Save

The prevalence of RET and ROS1 gene rearrangements in advanced lung adenocarcinomas pan-negative for other known drivers as revealed by FISH analysis

Meeting Abstract

Wang, L.; Islamdoust, N.; Drilon, A. E.; Rizvi, N.; Joubert, P.; Hasanovic, A.; Wynne, M.; Intrieri, J.; Jhanwar, S. C.; Ladanyi, M.
Journal of Molecular Diagnostics (2013)

Fulltext@MSK | Save

Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab

Journal Article

Hellmann, M. D.; Chaft, J. E.; Rusch, V.; Ginsberg, M. S.; Finley, D. J.; Kris, M. G.; Price, K. A. R.; Azzoli, C. G.; Fury, M. G.; Riely, G. J.; more...
Cancer Chemotherapy and Pharmacology (2013)

Fulltext@MSK | Save

Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small-cell lung cancers

Journal Article

Chaft, J. E.; Rusch, V.; Ginsberg, M. S.; Paik, P. K.; Finley, D. J.; Kris, M. G.; Price, K. A. R.; Azzoli, C. G.; Fury, M. G.; Riely, G. J.; more...
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

Nivolumab plus Ipilimumab in advanced melanoma

Journal Article

Wolchok, J. D.; Kluger, H.; Callahan, M. K.; Postow, M. A.; Rizvi, N. A.; Lesokhin, A. M.; Segal, N. H.; Ariyan, C. E.; Gordon, R. A.; Reed, K.; more...
New England Journal of Medicine (2013)

Fulltext@MSK | Save

Phase I study of U3-1287, a fully human anti-HER3 monoclonal antibody, in patients with advanced solid tumors

Journal Article

LoRusso, P.; Jänne, P. A.; Oliveira, M.; Rizvi, N.; Malburg, L.; Keedy, V.; Yee, L.; Copigneaux, C.; Hettmann, T.; Wu, C. Y.; more...
Clinical Cancer Research (2013)

Fulltext@MSK | Save

Response to cabozantinib in patients with RET fusion-positive lung adenocarcinomas

Journal Article

Drilon, A.; Wang, L.; Hasanovic, A.; Suehara, Y.; Lipson, D.; Stephens, P.; Ross, J.; Miller, V.; Ginsberg, M.; Zakowski, M. F.; more...
Cancer Discovery (2013)

Fulltext@MSK | Save

Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors

Journal Article

Yu, H. A.; Sima, C. S.; Huang, J.; Solomon, S. B.; Rimner, A.; Paik, P.; Pietanza, M. C.; Azzoli, C. G.; Rizvi, N. A.; Krug, L. M.; more...
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save